SPERA PHARMA was spun out from Takeda Pharmaceutical Company by a group of researchers and engineers with CMC experience. It started operations in July 2017 with a research team of experts who had experience in CMC research for process chemistry, formulation development and analytical development in the Pharmaceutical Sciences Division of Takeda. By opening up their technology and know-how they provide services that contribute to the creation of superior pharmaceuticals and innovative medicines.
page top